Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-29

FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)

View source ↗

Summary

The FDA approved a supplemental NDA for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) from Bayer Healthcare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTRIMIN ULTRA ATHLETES FOOT (BUTENAFINE HYDROCHLORIDE)

Snippet

SUPPL AP for LOTRIMIN ULTRA ATHLETES FOOT (BUTENAFINE HYDROCHLORIDE)